08.06.2012 • News

Laura L. Parks appointed President and Business Unit Director at DSM Pharmaceutical Products

Laura L. Parks, Ph.D., currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM has been appointed President and Business Unit Director of DSM Pharmaceuticals as of June 1, 2012.

Laura will continue to report to Alexander R. Wessels, President and Chief Executive Officer of DSM Pharmaceutical Products, as a member of the Management Team.

 

Dr. Parks joined DSM in 2008. Prior to DSM, she was with World Financial Group, and Solae (a Division of DuPont), a public company of over 10,000 employees, as Vice President of Sales.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.